Multiple-variable dose regimen for treating TNFa-related disorders

Multiple-variable dose methods for treating TNFalpha-related disorders, including Crohn's disease and psoriasis, comprising administering TNFalpha inhibitors, including TNFalpha antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction o...

Full description

Saved in:
Bibliographic Details
Main Authors TAYLOR LORI K, PAULSON SUSAN K, GRANNEMAN GEORGE R, HOFFMAN REBECCA S, CHARTASH ELLIOT K, YAN PHILIP, PENG JOANNA Z
Format Patent
LanguageEnglish
Published 16.05.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Multiple-variable dose methods for treating TNFalpha-related disorders, including Crohn's disease and psoriasis, comprising administering TNFalpha inhibitors, including TNFalpha antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction or loading phase followed by administration of the agent in a maintenance or treatment phase, wherein the TNF-inhibitor is administered in a higher dosage during the induction phase.
AbstractList Multiple-variable dose methods for treating TNFalpha-related disorders, including Crohn's disease and psoriasis, comprising administering TNFalpha inhibitors, including TNFalpha antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction or loading phase followed by administration of the agent in a maintenance or treatment phase, wherein the TNF-inhibitor is administered in a higher dosage during the induction phase.
Author PAULSON SUSAN K
YAN PHILIP
HOFFMAN REBECCA S
CHARTASH ELLIOT K
TAYLOR LORI K
GRANNEMAN GEORGE R
PENG JOANNA Z
Author_xml – fullname: TAYLOR LORI K
– fullname: PAULSON SUSAN K
– fullname: GRANNEMAN GEORGE R
– fullname: HOFFMAN REBECCA S
– fullname: CHARTASH ELLIOT K
– fullname: YAN PHILIP
– fullname: PENG JOANNA Z
BookMark eNqNyjsOwjAQRVEXUPDbw0jUlnCyghAR0UBDqKMBv0SWHNsaG9YPBQuguae5a7UIMWCljpeXLy556DeL44cH2ZhBgsnNCDRGoSLg4sJE_bVjLfBcYMm6HMVC8lYtR_YZu58bte9OfXvWSHFATvxEQBnut-pgalN9axpT_3d9ACKZNJE
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2013122011A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2013122011A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:54:17 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2013122011A13
Notes Application Number: US201213433205
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130516&DB=EPODOC&CC=US&NR=2013122011A1
ParticipantIDs epo_espacenet_US2013122011A1
PublicationCentury 2000
PublicationDate 20130516
PublicationDateYYYYMMDD 2013-05-16
PublicationDate_xml – month: 05
  year: 2013
  text: 20130516
  day: 16
PublicationDecade 2010
PublicationYear 2013
RelatedCompanies PAULSON SUSAN K
YAN PHILIP
HOFFMAN REBECCA S
CHARTASH ELLIOT K
TAYLOR LORI K
GRANNEMAN GEORGE R
PENG JOANNA Z
RelatedCompanies_xml – name: CHARTASH ELLIOT K
– name: YAN PHILIP
– name: GRANNEMAN GEORGE R
– name: PAULSON SUSAN K
– name: PENG JOANNA Z
– name: HOFFMAN REBECCA S
– name: TAYLOR LORI K
Score 2.8965557
Snippet Multiple-variable dose methods for treating TNFalpha-related disorders, including Crohn's disease and psoriasis, comprising administering TNFalpha inhibitors,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Multiple-variable dose regimen for treating TNFa-related disorders
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130516&DB=EPODOC&locale=&CC=US&NR=2013122011A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVfFRZUHJbbFp8zwEMS-KkLTYRHorSXYDgibFRP37zi6p9tRb2IVhE5j55tvMfANwj5iulUWRUxPzY6oZmUZz1SzoRMeYWE4yZkl1_ig2pqn2vNSXPXjf9MJIndAfKY6IHlWgv7cyXq__L7F8WVvZPORvuFQ_honjKx07xoCsq4biu04wn_kzT_E8J10o8YvcU8cC7Z6QK-2JRFoo7QevruhLWW-DSngM-3O0V7Un0OPVAA69zey1ARxE3S9vfOy8rzkFN-qq_-g3MlzR80RY3XAihit88Ipg_klk4TjCEUniMKOyU4UzwjqNzeYM7sIg8aYUD7P6e_dVutg--eQc-lVd8QsgmlEisxrpbMRNITBoqxmSHW5bpZUzXtqXMNxl6Wr39jUcjeXcB52qxhD67ecXv0H0bfNb-dF-AQ69h68
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKc43nYqXqQGlb8F1vT8Use1K1bUbrpW9jV5SELQdturf9zR0uqe9hQRCEjjny5ec8x2AW8R0OU_ThGp4P6ayGss0EbWUSgr6xFyKM52r8_uB6kXy00JZdOB9nQvDdUJ_uDgiWlSK9l5zf736f8RyeGxldZe8YVd574amI7TsGB2yIqqCY5nj2dSZ2oJtm9FcCF74mDhq0O4BudKOhqSQk6VXq8lLWW2CinsAuzOcr6gPocOKPvTsde21Puz57Zc3Nlvrq47A8tvoP_qNDLfJeSJZWTHSFFf4YAXB-yfhgeMIRyQM3JjyTBWWkazV2KyO4cYdh7ZHcTHLv70vo_nmyqUT6BZlwU6ByGqOzGqoZEOmNQKDhhgj2WGGnutJxnLjDAbbZjrfPnwNPS_0J8vJY_B8AfsjXgNCoaI6gG79-cUuEYnr5Iof4C-MD4qZ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Multiple-variable+dose+regimen+for+treating+TNFa-related+disorders&rft.inventor=TAYLOR+LORI+K&rft.inventor=PAULSON+SUSAN+K&rft.inventor=GRANNEMAN+GEORGE+R&rft.inventor=HOFFMAN+REBECCA+S&rft.inventor=CHARTASH+ELLIOT+K&rft.inventor=YAN+PHILIP&rft.inventor=PENG+JOANNA+Z&rft.date=2013-05-16&rft.externalDBID=A1&rft.externalDocID=US2013122011A1